Safety and efficacy of mitemcinal fumarate (GM-611) in diabetic gastroparesis: 12-week, multi-center, double-blind, placebo-contolled, phase 2b study (GM-611-05)

被引：0
|
作者：
Faichney, JD
Goldstein, BJ
Fogel, RP
Mccallum, RW
机构：
来源：
DIABETES | 2005年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A512 / A512
页数：1
相关论文
共 33 条
  • [31] THE IDEAL STUDY: A PHASE 2 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, MULTI-CENTER STUDY TO EVALUATE THE SAFETY AND EFFICACY OF THE ORAL α4β7 INTEGRIN PEPTIDE ANTAGONIST PN-943 IN PATIENTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS
    Plevy, Scott E.
    Panes, Julian
    D'Haens, Geert R.
    Jairath, Vipul
    Feagan, Brian G.
    Gupta, Suneel K.
    Hwang, C. C.
    Sands, Bruce E.
    Armuzzi, Alessandro
    Reinisch, Walter
    Schreiber, Stefan
    Sandborn, William J.
    GASTROENTEROLOGY, 2022, 162 (07) : S1394 - S1395
  • [32] A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study Evaluating the Efficacy and Safety of Orelabrutinib Plus R-CHOP Versus Placebo Plus R-CHOP in Treatment-Naive Patients with Mcd Subtype Diffuse Large B-Cell Lymphoma
    Xu, Pengpeng
    Fan, Ni
    Tian, Yamin
    Tang, Xinran
    Zhang, Bin
    Zhou, Wei
    Zhao, Renbin
    Zhao, Weili
    BLOOD, 2022, 140 : 12110 - 12110
  • [33] INTERNATIONAL, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 STUDY ASSESSING IN PARALLEL GROUPS THE EFFICACY AND SAFETY OF 2 DOSES OF PXT3003 IN PATIENTS WITH CHARCOT-MARIE-TOOTH DISEASE TYPE 1A TREATED FOR 15 MONTHS
    Attarian, S.
    De Visser, M.
    Roberts, M.
    Thomas, F.
    Sevilla, T.
    Van Damme, P.
    Young, P.
    Bertrand, V
    Guedj, M.
    Scart-Gres, C.
    Lewis, R.
    Vallat, J-M
    Lehert, P.
    Cornblath, D. R.
    Cohen, D.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2016, 21 (03) : 234 - 234
1234